Regimen | General ward inpatients (n = 2090) | ICU patients (n = 168) |
---|---|---|
Consistent with guideline | 795(38.0) | 1(0.6) |
 β-lactam | 415(19.8) | 0(0) |
 Fluoroquinolone | 312(14.9) | 0(0) |
 β-lactam + macrolide | 68(3.3) | 0(0) |
 β-lactam + fluoroquinolone | 0(0) | 1(0.6) |
Undertreated by guideline | 201(9.6) | 120(71.4) |
 β-lactam | 153(7.3) a | 92(54.8)b |
 β-lactam + macrolide | 21(1.0)a | 1(0.6) |
 Macrolide | 15(0.7) | 0(0) |
 Fluoroquinolone +/− β-lactamc | 0(0) | 26(15.5) |
 Other combination | 12(0.6) | 1(0.6) |
Overtreated by guideline | 1094(52.3) | 47(28.0) |
 Antipseudomonal β-lactamd | 530(25.4)# | 0(0) |
 Fluoroquinolone +β-lactam/ othere | 451(21.6) ## | 37(22.0)* |
 Antipseudomonal β-lactamd + macrolide | 46(2.2) ### | 5(3.0)** |
 Antipseudomonal β-lactamd + othere | 39(1.9) #### | 2(1.2) *** |
 Fluoroquinolone + macrolide | 12(0.6) | 0(0) |
 β-lactam +quinolone+ othere | 8(0.3) | 3(1.8) **** |
 β-lactam +macrolide+ fluoroquinolone /othere | 8(0.3) | 0(0) |